Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Tongjitang Mulls Merger Proposal

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - New York-listed Tongjitang Chinese Medicines took one step closer to privatization last week, when it put together a special committee to evaluate a merger proposal from its two largest shareholders
Advertisement

Related Content

Tongjitang Pins Loss On Delayed Implementation Of China's Essential Drug List; Proposed Buyout Still Under Review
Tongjitang Pins Loss On Delayed Implementation Of China's Essential Drug List; Proposed Buyout Still Under Review
China's Generic Companies Leaning Toward Innovation To Target Global Market: FT China Healthcare And Life Science Summit
China's Generic Companies Leaning Toward Innovation To Target Global Market: FT China Healthcare And Life Science Summit
Advertisement
UsernamePublicRestriction

Register

SC074653

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel